DrugDashboards

Dexamethasone Sodium Phosphate

Dexamethasone Sodium Phosphate · DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mL · Injection, Solution · Intra-Articular; Intralesional; Intramuscular; Intravenous; Soft Tissue · Eugia US LLC

NDC 55150-0237-01 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 1 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

20 companies supply this market — deep enough that no single failure threatens the supply. The price has jumped 103% in a year, to $1.39 per unit — sharp rises like this often mean supply is already tightening. It is in shortage right now. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$1.00$2.00$3.00Jun 2016Sep 2020$1.39
18 price points · per · last surveyed Invalid DateSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$19.50
Reported to Texas DSHS · 2024 annual filing · Auromedics Pharma Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$22,222
3,966 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for dexamethasone sodium phosphate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $14.09 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA206781
TE code
—
Approval date
Dec 1, 2015
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)Feb 8, 2019
    month 91 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

  • Class II · OngoingMay 23, 2024
    Eugia US LLC — Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Manufacturers of Dexamethasone Sodium Phosphate (Injection, Solution)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Amneal Pharmaceuticals LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 3, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Micro Labs LimitedDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 3, 2026
Mylan Institutional LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 3, 2026
Mylan Institutional LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 3, 2026
Sportpharm LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 22, 2026Sep 3, 2026
Sportpharm LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 3, 2026
Advanced Rx of Tennessee, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Armas PharmaceuticalsDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLC.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Phlow CorporationDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.DEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Aug 31, 2026
Medical Purchasing Solutions, LLCDEXAMETHASONE SODIUM PHOSPHATE 4 mg/mLJul 15, 2026Aug 31, 2026
Medical Purchasing Solutions, LLCDEXAMETHASONE SODIUM PHOSPHATE 10 mg/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dexamethasone Sodium Phosphate — NDC 55150-0237-01," retrieved September 3, 2026, https://drugdashboards.com/drug/55150023701.

Free to cite with attribution — see how the data is put together.